about
Genes of susceptibility to early neurodegenerative changes in the rat retina and brain: analysis by means of congenic strainsAlzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1.Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease.MS2 phage ribonucleoproteins as exogenous internal control for RT-qPCR data normalization in gene expression study of developing rat brain.Therapeutic action of the mitochondria-targeted antioxidant SkQ1 on retinopathy in OXYS rats linked with improvement of VEGF and PEDF gene expressionAmyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats.Application of quantitative trait locus mapping and transcriptomics to studies of the senescence-accelerated phenotype in rats.Quantitative trait loci on chromosome 1 for cataract and AMD-like retinopathy in senescence-accelerated OXYS rats.The age-associated loss of ischemic preconditioning in the kidney is accompanied by mitochondrial dysfunction, increased protein acetylation and decreased autophagy.The mitochondria-targeted antioxidant SkQ1 but not N-acetylcysteine reverses aging-related biomarkers in rats.Rat retinal transcriptome: effects of aging and AMD-like retinopathyAn attempt to prevent senescence: a mitochondrial approach.Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies.Identification of functional networks associated with cell death in the retina of OXYS rats during the development of retinopathy.Antioxidant SkQ1 delays sarcopenia-associated damage of mitochondrial ultrastructure.Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune ArthritisNeuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence.An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology.Mitochondria-targeted antioxidant SkQ1 inhibits age-dependent involution of the thymus in normal and senescence-prone rats.Improving Bone Microarchitecture in Aging with Diosgenin Treatment: A Study in Senescence-Accelerated OXYS Rats.Morphometric Examination of Mitochondrial Ultrastructure in Aging Cardiomyocytes.Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland.Age-associated changes in oxidative damage and the activity of antioxidant enzymes in rats with inherited overgeneration of free radicals.Contributions of age-related alterations of the retinal pigment epithelium and of glia to the AMD-like pathology in OXYS rats.Development of behavioural dysfunctions in accelerated-senescence OXYS rats is associated with early postnatal alterations in brain phosphate metabolism.The Mitochondria-Targeted Antioxidant SkQ1 Downregulates Aryl Hydrocarbon Receptor-Dependent Genes in the Retina of OXYS Rats with AMD-Like RetinopathyDynamics of structural and functional changes in hepatocyte mitochondria of senescence-accelerated OXYS rats.Effect of long-term cold exposure on activities of cytochrome P450-containing monooxygenases and glutathione S-transferase in rat liver microsomes.The therapeutic effect of mitochondria-targeted antioxidant SkQ1 and Cistanche deserticola is associated with increased levels of tryptophan and kynurenine in the rat lens.Clinical and morphological characteristics of chorioretinal degeneration in early aging OXYS rats.Changes in physicochemical parameters and alpha-crystallin expression in the lens during cataract development in OXYS rats. 5.Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals.Bone mineralization in senescence-accelerated OXYS rats.19F NMR measurements of NO production in hypertensive ISIAH and OXYS rats.Prevention of age-related macular degeneration-like retinopathy by rapamycin in rats.The influence of changes in expression of redox-sensitive genes on the development of retinopathy in rats.Age-dependent guanine oxidation in DNA of different brain regions of Wistar rats and prematurely aging OXYS rats.Increased stress reactivity as a possible factor of early degenerative changes in OXYS rats.Peculiarities of bone marrow hemopoiesis in early aging OXYS rats.Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats.
P50
Q28559519-841932C0-F986-4E16-B121-C6D098468104Q30667629-EDEF5F5C-89DB-4275-9AED-6588675E4BBCQ30760387-A9615D5C-BDEB-49D6-9470-E842B77375D9Q30841631-C941621E-7C12-4767-99DA-A443C39ACBD0Q33959341-BAA21B98-482B-4BE3-8681-67C1D83891BAQ35176315-0DF3E42C-CAC3-4B64-AA09-A307E7F8439DQ35539015-EEC662BB-C28D-4F65-94C4-5EDD0110B649Q35799827-CB014567-76AB-4CF4-9C2B-7E9723659EA2Q36308199-E7569710-7108-4829-913A-EE41EF574FC4Q36455187-B2B4EF04-C112-43DD-8A04-F1BFC1FCF000Q37018247-A756E72F-ADB1-4BB3-99DD-A0E46303BB22Q37374360-C4FAC8E2-49C3-4446-B27A-D0C3E322E49CQ37832525-5689BCB0-6A06-40B9-950E-27E92A51DFFAQ38456773-CDE896F4-63D8-45BA-A8F8-C6BE7BF7A36CQ38552694-26560092-A145-49A7-BBE9-32C7DFB2D9F1Q38764856-BA97143D-1C0A-48E8-9A23-CE7A53A599C5Q38795360-BE387289-563E-445E-A563-EC1B4D9E51C3Q39281122-021308D4-0085-43E1-85B0-C2D35AE0AE43Q39330017-14D4749B-283D-40B8-A552-C4D0BB69AF40Q40521336-52D7F122-8114-4B71-8E73-50BF8E3330EAQ40838584-4DCD455D-1FBB-487F-823E-2344A8FB4782Q41861443-6F033E07-3DF0-410C-A285-27AE63067032Q41974459-A60DE5BF-2FE1-4C6B-BBC5-2931E0D402D5Q42326574-CF647801-A718-47D0-A252-72248866A51CQ42674197-EB37E9B3-ECCB-4BC5-93BF-2B02803C3DC1Q42772602-9018F272-5037-45E2-AE37-352EED6CF5E6Q43802570-E9417614-7A2B-4B2C-A298-63A517F8A0F5Q45235131-F539E884-4D00-4DF4-87B3-438C2F045E2FQ45404995-4A5E79B6-F3AF-4B74-9938-F098F53CA319Q45986370-E4723845-9FE7-4DE1-B7E3-E1BE276BC0C4Q46177101-53079BB9-E877-40A5-9F27-7CC2EE6767C7Q46177106-151836C5-BEF8-4DE2-895C-4483C96D9D02Q46287792-8BCA9B47-E0EB-43FB-A794-DA9832483677Q46409549-DE3535B9-DA58-4CF9-B075-1014A572E65EQ46476515-069AB20F-CB3E-4FDF-9C66-6367453A337AQ46510112-85735D43-F718-404D-B376-4006220F8E8EQ46557864-F2E04D79-DB9D-46D4-8570-B8781CCA0261Q46607318-169F1D91-C0BE-443D-91AD-F43B7B90CF10Q46767335-37F6EF9A-0565-4E23-937F-B57C062A4565Q46771873-DE23DB07-457C-42A8-A7C2-0FCE1723E6B5
P50
description
researcher
@en
wetenschapper
@nl
name
Kolosova NG
@nl
Natalija Gorislawowna Kolossowa
@de
Nataliya Kolosova
@en
Наталия Гориславовна Колосова
@ru
type
label
Kolosova NG
@nl
Natalija Gorislawowna Kolossowa
@de
Nataliya Kolosova
@en
Наталия Гориславовна Колосова
@ru
altLabel
Kolosova NG
@en
Natalija Kolossowa
@de
Nataliya G Kolosova
@en
prefLabel
Kolosova NG
@nl
Natalija Gorislawowna Kolossowa
@de
Nataliya Kolosova
@en
Наталия Гориславовна Колосова
@ru
P1053
P-3178-2015
P106
P1153
35570570900
P21
P2798
P31
P496
0000-0003-2398-8544